|
× |
 |
Amisulpride: A Useful Second-Generation Antipsychotic Omitted From the US Residency Training Curriculum PDF |
$40.00 |
|
$40.00 |
|
× |
|
Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Low Hemoglobin Levels and Risk of Developing Depression in the Elderly: Results From the Prospective PRO.V.A. Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effects of Antipsychotic Treatment on Tardive Dyskinesia: A 6-Month Evaluation of Patients From the European Schizophrenia Outpatient Health Outcomes (SOHO) Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Genetic Studies of Drug Response and Side Effects in the STAR*D Study, Part 2 PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risperidone, 2 mg/day vs. 4 mg/day, in First-Episode, Acutely Psychotic Patients: Treatment Efficacy and Effects on Fine Motor Functioning PDF |
$40.00 |
|
$40.00 |
|
× |
|
Venlafaxine in the Treatment of Dysthymia: An Open-Label Study PDF |
$40.00 |
|
$40.00 |
|
|
